中文
EnglishCatalog No : | IPB0200 |
Reactivity: | Human; Mouse; Rat |
Applications: | WB; IHC-p; ELISA |
Dilution: | WB: 1:500-1:2000 IHC: 1:50-1:200 ELISA: 1:10000 |
Gene Name: | APOE |
Protein Name: | Apolipoprotein E |
Human Gene Id: | 348 |
Swiss-Prot: | P02649 |
Formulation: | Liquid in PBS containing 50% glycerol, 05% BSA and 002% sodium azide |
Source: | Rabbit |
Purification: | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen |
Concentration: | 1 mg/ml |
Storage&Stability: | -20°C/1 year |
Subcellular Location: | Secreted Secreted, extracellular space Secreted, extracellular space, extracellular matrix In the plasma, APOE is associated with chylomicrons, chylomicrons remnants, VLDL, LDL and HDL lipoproteins (PubMed:1911868, PubMed:8340399) Lipid poor oligomeric APOE is associated with the extracellular matrix in a calcium- and heparan-sulfate proteoglycans-dependent manner (PubMed:9488694) Lipidation induces the release from the extracellular matrix (PubMed:9488694) |
MW: | 36154 |
Background: | The protein encoded by this gene is a major apoprotein of the chylomicron It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants |
SPECIES
APPLICATION
TITLE